Swiss Chemical Society

11. Swiss Course on Medicinal Chemistry 2014

11. Swiss Course on Medicinal Chemistry
Leysin, Switzerland
October 12-17, 2014

This five-day Medicinal Chemistry School, that is organized by the Division of Medicinal Chemistry and Chemical Biology of the Swiss Chemical Society, will focus on most modern aspects associated with small molecule drug discovery, highlighting the relevance of hit generation, lead finding and lead optimization technologies.

Program and CV of the speakers

More details on www.scg.ch/leysin/2014

David Spichiger, SCS
01.10.2014

MipTec 2014: Peptide Therapeutics Forum, Spt 23, 2014

Tuesday, September 23, 2014
Congress Center Basel, Room 5

The Peptide Therapeutics Forum 2014 will be divided up in a morning session on “Peptide Discovery” and afternoon presentations on “Development of therapeutic Peptides”. The first part provides some insight into latest methodologies for peptide synthesis and interesting projects more from a preclinical perspective. The afternoon session is dedicated to more advanced peptides. Topics to be discussed include intracellular delivery of peptides, diagnostic imaging and specific disease associated themes, e.g. peptides from the Incretin family to treat diabetes & obesity. This event is thought to disseminate information on latest developments in the broad field of therapeutic peptides and to enable networking of interested parties from academia and industries.

Organizers: Thomas Vorherr, Eric Kitas

Link to the forum website.

Flyer Peptide Therapeutics Forum, Spt 23, 2014

Link to the Interactive Planner
Please subscribe to our Newsletter so stay informed about the latest updates.

David Spichiger, SCS
05.09.2014

Prof. Karl-Heinz Altmann awarded the Paul Ehrlich Prize 2014

"The French Medicinal Chemistry Society (SCT) and Janssen-Cilag S.A. are very pleased to annonce that the Paul Ehrlich Prize 2014 is attributed to Professor Karl-Heinz ALTMANN (Institut of Pharmaceutical Sciences, ETH Zürich, Switzerland) recognizing his outstanding contribution and substantial results in the field of the chemistry and chemical biology of pharmaceutically relevant natural products and analogs.

Professor Altmann will deliver a plenary lecture at the 50th International Conference on Medicinal Chemistry (RICT 2014) in Rouen, Normandy, on July 2-4 2014.

For more information on RICT 2014, see: www.sct-asso.fr

140619 Altmann The Swiss Chemical Society thanks Prof. Altmann for his outstanding, scientific contributions and contratulates on this honorable award.
Karl-Heinz Altmann is a Member of the SCS divisional board of Medicinal Chemistry & Chemical Biology and was its President from 2011 - 2013.

Website of Prof. Karl-Heinz Altmann, Inst. f. Pharmazeutische Wiss. ,ETH Zürich

David Spichiger, SCS
19.06.2014

Preview: 3rd Japanese-Swiss Chemical Biology Symposium

140612 Header SJCBS-2014

3rd Japanese-Swiss Chemical Biology Symposium

University of Berne, Departmen of Chemistry and Biochemistry
Freiestrasse 3, 3012 Bern, Lecture Room EG16

Thu, October 2, 2014, 10:15 - Fri October 3, 2014, 17:30

Topics of the Symposium:

- Drug Design
- Peptides and Foldamers
- Nucleic Acids
- Imaging
- Biological Membranes
- Natural Products

Contact (Scientific Committee)

Jean-Louis Reymond (University of Bern, Chair)
Tamis Darbre (University of Bern)

More information

Website: http://www.sjchembio2014.unibe.ch

David Spichiger, SCS
12.06.2014

Mini Symposium: Kinetics and Thermodynamics in Drug Discovery: May 22, 2014

Mini-Symposium
«Kinetics and Thermodynamics in Drug Discovery»

Thursday, May 22, 2014, 13:30 - 17:45

Big Lecture Hall, Department of Chemistry
University of Basel, St. Johanns-Ring 19

This year's annual mini-symposium organized by the Division of Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society is dedicated to the topic of Kinetics and Thermodynamics in Drug Discovery.

This free event is gathering five globally renowed experts in the field that will showcase the importance of this topic in drug discovery.

Program

13.30h	Introduction
13.35h	Gerhard Klebe, University of Marburg Correlation of structure, thermodynamics and molecular dynamics to better understand drug binding
14.20h	David Swinney, Institute for Rare and Neglected Diseases Drug Discovery Application of binding kinetics to drug discovery
15.05h	Coffee Break
15.30h	Göran Dahl, AstraZeneca Pharmacokinetics and the drug-target residence time concept
16.15h	David Sykes, Novartis Institutes for Biomedical Research Exploring the relationship between β₂-adrenoceptor drug binding affinity/kinetic constants and physicochemical parameters
17.00	Russel Petter, Celgene Design and optimization of targeted covalent inhibitors